What the Latest Advances in Our Understanding of NASH Pathogenesis & Pathophysiology Can Tell Us About Past & Future Therapeutic Approaches

Time: 1:30 pm
day: Day 2 Stream 1 PM


• Outlining our understanding of the pathogenesis and pathophysiology of NAFLD and NASH, from the molecular to the whole-body level
• Hearing what clinical trials in NASH have taught us about different therapeutic targets and pathways, and why “what you measure” matters
• Integrating the latest basic, translational, and clinical research to improve NASH therapeutic target selection